These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 9245424

  • 1. Effects of sulfhydryl modification reagents on the kinase activity of the epidermal growth factor receptor.
    Woltjer RL, Staros JV.
    Biochemistry; 1997 Aug 12; 36(32):9911-6. PubMed ID: 9245424
    [Abstract] [Full Text] [Related]

  • 2. Modifications of the binding properties of the human VIP receptor of IGR39 cells by sulfhydryl reagents.
    Fouchier F, Forget P, Pic P, Marvaldi J, Pichon J.
    Eur J Cell Biol; 1992 Dec 12; 59(2):382-8. PubMed ID: 1337321
    [Abstract] [Full Text] [Related]

  • 3. Reactivity of the H(+)-ATPase from Kluyveromyces lactis to sulfhydryl reagents.
    Guerra G, Uribe S, Pardo JP.
    Arch Biochem Biophys; 1995 Aug 01; 321(1):101-7. PubMed ID: 7639507
    [Abstract] [Full Text] [Related]

  • 4. Complex effects of sulfhydryl reagents on ligand interactions with nucleoside transporters: evidence for multiple populations of ENT1 transporters with differential sensitivities to N-ethylmaleimide.
    Vyas S, Ahmadi B, Hammond JR.
    Arch Biochem Biophys; 2002 Jul 01; 403(1):92-102. PubMed ID: 12061806
    [Abstract] [Full Text] [Related]

  • 5. 5'-(p-fluorosulfonylbenzoyl)-2'(or 3')-(methylanthraniloyl)adenosine, fluorescent affinity labels for adenine nucleotide binding sites: interaction with the kinase active site of the receptor for epidermal growth factor.
    Scoggins RM, Summerfield AE, Stein RA, Guyer CA, Staros JV.
    Biochemistry; 1996 Jul 16; 35(28):9197-203. PubMed ID: 8703925
    [Abstract] [Full Text] [Related]

  • 6. Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.
    Putz T, Culig Z, Eder IE, Nessler-Menardi C, Bartsch G, Grunicke H, Uberall F, Klocker H.
    Cancer Res; 1999 Jan 01; 59(1):227-33. PubMed ID: 9892211
    [Abstract] [Full Text] [Related]

  • 7. Kinetics of activation of the tyrosine kinase of a deletion mutant of epidermal growth factor receptor missing the sites of self-phosphorylation.
    Sherrill JM, Kyte J.
    Biochemistry; 1999 Mar 09; 38(10):3106-11. PubMed ID: 10074364
    [Abstract] [Full Text] [Related]

  • 8. Effect of cysteine residues on the activity of arginyl-tRNA synthetase from Escherichia coli.
    Liu M, Huang Y, Wu J, Wang E, Wang Y.
    Biochemistry; 1999 Aug 24; 38(34):11006-11. PubMed ID: 10460155
    [Abstract] [Full Text] [Related]

  • 9. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells.
    Lee LT, Huang YT, Hwang JJ, Lee PP, Ke FC, Nair MP, Kanadaswam C, Lee MT.
    Anticancer Res; 2002 Aug 24; 22(3):1615-27. PubMed ID: 12168845
    [Abstract] [Full Text] [Related]

  • 10. The effects of sulfhydryl-modifying reagents on cholecystokinin-receptor interactions in guinea pig gastric glands.
    Ramani N, Praissman M.
    Endocrinology; 1989 Jun 24; 124(6):2821-9. PubMed ID: 2721447
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation.
    Lipson KE, Pang L, Huber LJ, Chen H, Tsai JM, Hirth P, Gazit A, Levitzki A, McMahon G.
    J Pharmacol Exp Ther; 1998 May 24; 285(2):844-52. PubMed ID: 9580635
    [Abstract] [Full Text] [Related]

  • 12. System A transport activity in normal rat hepatocytes and transformed liver cells: substrate protection from inactivation by sulfhydryl-modifying reagents.
    Chiles TC, Kilberg MS.
    J Cell Physiol; 1986 Dec 24; 129(3):321-8. PubMed ID: 3023402
    [Abstract] [Full Text] [Related]

  • 13. Modification of cysteine residues by N-ethylmaleimide inhibits annexin II tetramer mediated liposome aggregation.
    Singh TK, Liu L.
    Arch Biochem Biophys; 2000 Sep 15; 381(2):235-40. PubMed ID: 11032410
    [Abstract] [Full Text] [Related]

  • 14. Conformational changes of an Hsp70 molecular chaperone induced by nucleotides, polypeptides, and N-ethylmaleimide.
    Chirico WJ, Markey ML, Fink AL.
    Biochemistry; 1998 Sep 29; 37(39):13862-70. PubMed ID: 9753476
    [Abstract] [Full Text] [Related]

  • 15. Modulation of the protein tyrosine kinase activity and autophosphorylation of the epidermal growth factor receptor by its juxtamembrane region.
    Poppleton HM, Wiepz GJ, Bertics PJ, Patel TB.
    Arch Biochem Biophys; 1999 Mar 15; 363(2):227-36. PubMed ID: 10068444
    [Abstract] [Full Text] [Related]

  • 16. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
    Johnson FM, Saigal B, Donato NJ.
    J Cell Physiol; 2005 Nov 15; 205(2):218-27. PubMed ID: 15887238
    [Abstract] [Full Text] [Related]

  • 17. A basic residue, Lys 782, composes part of the ATP-binding site on the epidermal growth factor receptor tyrosine kinase.
    Klingbeil CK, Gill GN.
    Arch Biochem Biophys; 1999 Mar 01; 363(1):27-32. PubMed ID: 10049496
    [Abstract] [Full Text] [Related]

  • 18. PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner.
    Bos M, Mendelsohn J, Kim YM, Albanell J, Fry DW, Baselga J.
    Clin Cancer Res; 1997 Nov 01; 3(11):2099-106. PubMed ID: 9815602
    [Abstract] [Full Text] [Related]

  • 19. The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor.
    Shah BH, Olivares-Reyes JA, Catt KJ.
    Mol Pharmacol; 2005 Jan 01; 67(1):184-94. PubMed ID: 15465928
    [Abstract] [Full Text] [Related]

  • 20. Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA.
    Li J, Ma C, Huang Y, Luo J, Huang C.
    Oncogene; 2003 Jan 16; 22(2):211-9. PubMed ID: 12527890
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.